Aktionärsstruktur

Inhaber in %
Freefloat 97,28
Fidelity Management & Research Co. LLC 10,72
Vanguard Group, Inc. (Subfiler) 6,64
Capital Research & Management Co. (World Investors) 6,27
The Vanguard Group, Inc. 5,42
State Street Corp. 4,11
BlackRock Fund Advisors 3,83
Wellington Management Co. LLP 3,31
American Funds Growth Fund of America 3,02
Loomis, Sayles & Co. LP 2,95
Vanguard Total Stock Market Index Fund 2,66
BlackRock Institutional Trust Co. NA 2,41
Vanguard Health Care Fund 2,31
Fidelity Contrafund 2,22
Vanguard 500 Index Fund 2,05

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2015 2016 2017 2018 2019
Personal am Ende des Jahres 4.300 5.400 6.200 7.400 8.100
Umsatz pro Mitarbeiter in Mio. EUR 0,95 0,90 0,95 0,91 0,97

Bilanz (in Mio. EUR) - Aktiva

2015 2016 2017 2018 2019
Summe Umlaufvermögen 2.915 3.180 4.335 6.448 7.689
Summe Anlagevermögen 4.018 4.928 6.848 9.466 11.804
Summe Aktiva 5.630 6.983 8.812 11.735 14.805

Bilanz (in Mio. EUR) - Passiva

2015 2016 2017 2018 2019
Gesamtverschuldung/ -verbindlichkeiten 363 479 703 709 714
Summe Fremdkapital 1.976 2.533 2.668 2.977 3.716
Summe Eigenkapital 3.655 4.449 6.144 8.757 11.090
Summe Passiva 5.630 6.983 8.812 11.735 14.805

Adresse

777 Old Saw Mill River Road, 10591-6707 Tarrytown
Telefon +1 (914) 847-7000
Internet http://www.regeneron.com

Management

Alan Shuldiner
Vice President-Translational Genetics
Andrew J. Murphy
Executive Vice President-Research
Arthur Frederick Ryan
Independent Director
Beth F. Levine
Chief Compliance Officer & Senior Vice President
Bonnie L. Bassler
Independent Director
Christine A. Poon
Independent Director
Christopher Robert Fenimore
Vice President & Controller
Daniel P. Van Plew
EVP, GM-Industrial Operations & Product Supply
David Weinreich
Senior Vice President-Global Clinical Development
George Damis Yancopoulos
Co-President, Director & Chief Scientific Officer
George L. Sing
Independent Director
Gerald Underwood
Senior Vice President-Technical Operations
Huda Y. Zoghbi
Independent Director
Joseph J. LaRosa
Secretary, Executive VP & General Counsel
Joseph L. Goldstein
Independent Director
Justin Holko
Head-Investor Relations
Kerry K. Reinertsen
Senior Vice President-Strategic Alliances
Leonard S. Schleifer
Co-President, Chief Executive Officer & Director
Marc Tessier-Lavigne
Independent Director
Marion McCourt
Senior Vice President & Commercial Head
Michael S. Brown
Independent Director
N. Anthony Coles
Independent Director
Ned Braunstein
SVP-Regulatory Affairs & Global Patient Safety
Neil Stahl
Executive VP-Research & Development
Nouhad Husseini
Vice President-Business Development
P. Roy Vagelos
Chairman
Patrice Gilooly
Senior VP-Quality Assurance & Operations
Robert E. Landry
Chief Financial Officer & Executive VP-Finance
Sally A. Paull
Senior Vice President-Human Resources